Search Results - M. V. Ezhov

Refine Results
  1. 1
    ADDRESS TO THE READERS

    ADDRESS TO THE READERS by M. V. Ezhov

    Published 2017-06-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    NOVEL OPPORTUNITIES TO REACH THE TARGET LEVELS OF LOW DENSITY CHOLESTEROL

    NOVEL OPPORTUNITIES TO REACH THE TARGET LEVELS OF LOW DENSITY CHOLESTEROL by M. V. Ezhov

    Published 2014-08-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE

    RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE by M. V. Ezhov

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders

    Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders by I. V. Sergienko, M. V. Ezhov

    Published 2023-12-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY

    VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY by E. P. Trukhacheva, M. V. Ezhov

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Highlights of the 92nd European Atherosclerosis Society (EAS) Congress, May 26-29, 2024, Lyon, France

    Highlights of the 92nd European Atherosclerosis Society (EAS) Congress, May 26-29, 2024, Lyon, France by M. V. Ezhov, U. V. Chubykina

    Published 2024-10-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION

    THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION by R. N. Adzhiev, M. S. Safarova, M. V. Ezhov

    Published 2015-09-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Familial hypercholesterolemia: current status of the problem, treatment, and prevention

    Familial hypercholesterolemia: current status of the problem, treatment, and prevention by S. A. Bliznyuk, M. G. Bubnova, M. V. Ezhov

    Published 2020-11-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    ANTISENSE OLIGONUCLEOTIDES AND THERAPEUTICAL MONOCLONAL ANTIBODIES AS A BASEMENT FOR NOVEL BIOLOGICAL LIPIDLOWERING DRUGS

    ANTISENSE OLIGONUCLEOTIDES AND THERAPEUTICAL MONOCLONAL ANTIBODIES AS A BASEMENT FOR NOVEL BIOLOGICAL LIPIDLOWERING DRUGS by O. I. Afanasieva, M. V. Ezhov, S. N. Pokrovsky

    Published 2018-09-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Rosuvastatin safety and efficacy in coronary heart disease patients

    Rosuvastatin safety and efficacy in coronary heart disease patients by I. V. Sergienko, M. V. Ezhov, V. P. Masenko

    Published 2006-10-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    The era of targeted therapy for hyperlipidemia

    The era of targeted therapy for hyperlipidemia by U. V. Chubykina, A. V. Tyurina, M. V. Ezhov

    Published 2024-10-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare

    Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare by O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel

    Published 2019-09-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment

    Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment by A. M. Namitokov, U. V. Chubykina, V. K. Zafiraki, M. V. Ezhov

    Published 2025-04-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)

    INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а) by E. A. Utkina, O. I. Afanasieva, N. V. Artemyeva, M. V. Ezhov, S. N. Pokrovsky

    Published 2017-06-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Regional ocular blood flow in patients with I-II stage hypertension and subclinical atherosclerosis

    Regional ocular blood flow in patients with I-II stage hypertension and subclinical atherosclerosis by T. N. Kiseleva, M. V. Ezhov, N. A. Adzhemian, V. E. Tankovsky, N. V. Ilyina

    Published 2018-10-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study)

    Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) by M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov

    Published 2023-05-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Guidelines on the organization of medical care to patients with hereditary atherogenic lipid disorders in the Russian regions

    Guidelines on the organization of medical care to patients with hereditary atherogenic lipid disorders in the Russian regions by A. A. Sokolov, O. Yu. Alexandrova, V. V. Kashtalap, O. L. Barbarash, M. V. Ezhov

    Published 2017-03-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Anti-aggregant therapy in patients with coronary heart disease and gastric ulcer

    Anti-aggregant therapy in patients with coronary heart disease and gastric ulcer by A. B. Sumarokov, L. I. Buryachkovskaya, M. V. Ezhov, I. A. Uchitel’, Yu. V. Dotsenko

    Published 2010-10-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE

    CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE by O. I. Afanasieva, M. V. Ezhov, M. I. Afanasieva, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women

    Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women by O. I. Afanasyeva, M. V. Ezhov, M. S. Safarova, M. I. Afanasyeva, I. Yu. Adamova, S. N. Pokrovsky

    Published 2010-12-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: